Effectiveness of monoclonal antibody therapy for COVID-19 patients using a risk scoring system

INTRODUCTION: Monoclonal antibody therapy has been reported to be highly effective for preventing hospitalisation and severe cases in patients with Coronavirus Disease 2019 (COVID-19). However, since the drug is not readily available, it is important to rapidly and appropriately identify high-risk p...

Descripción completa

Detalles Bibliográficos
Autores principales: Mutoh, Yoshikazu, Umemura, Takumi, Ota, Aiko, Okuda, Keisuke, Moriya, Ryoma, Tago, Mayumi, Soejima, Kazuaki, Noguchi, Yoichiro, Bando, Tomohiro, Ota, Sho, Sato, Tomonori, Hirota, Shuko, Hagimoto, Satoshi, Takei, Reoto, Sasano, Hajime, Yamano, Yasuhiko, Kataoka, Kensuke, Yokoyama, Toshiki, Matsuda, Toshiaki, Kimura, Tomoki, Ichihara, Toshihiko, Kondoh, Yasuhiro
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Japanese Society of Chemotherapy and The Japanese Association for Infectious Diseases. Published by Elsevier Ltd. 2022
Materias:
Note
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8629723/
https://www.ncbi.nlm.nih.gov/pubmed/34863647
http://dx.doi.org/10.1016/j.jiac.2021.11.022

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8629723/
https://www.ncbi.nlm.nih.gov/pubmed/34863647
http://dx.doi.org/10.1016/j.jiac.2021.11.022

Ejemplares similares